title: [Gastrozepin therapy of gallbladder motility disorders in patients with ischemic heart disease].
abstract: Submitted in the paper are results of studies on gastrocepin effects on degree of clinical symptoms, contractility of the gall bladder, and power of the threshold load in patients with ischemic heart disease and disordered motor function of the bile tracts. Gastrocepin is shown to increase contractility of the gall bladder and facilitate normalization of the Oddie's sphincter tone; it makes for the reduction in the incidence of anginal attacks and increase in the physical exercise tolerance in patients with stabile functional class I and II angina pectoris of effort.
authors.forename: V H
authors.initials: VH
authors.lastname: Lyzohub
authors.forename: D A
authors.initials: DA
authors.lastname: Pliskevyvch
authors.forename: L S
authors.initials: LS
authors.lastname: Nikoliuk
authors.forename: O V
authors.initials: OV
authors.lastname: Savchenko
mesh_terms: D000328:Adult; D000787:Angina Pectoris / Q000453:epidemiology; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D005705:Gallbladder Diseases / Q000188:drug therapy*; D016473:Gallbladder Emptying; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications* / Q000188:drug therapy; D010890:Pirenzepine / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000897:Anti-Ulcer Agents; D010890:Pirenzepine
vernacular_title: Likuvannia hastrotsepinom porushen' motoryky zhovchovyvidnykh shliakhiv u khvorykh na ishemichnu khvorobu sertsia.